Top Ophthalmologist Dr. I. Paul Singh Recognized Globally for Excellence in Eye Care
We’re thrilled to announce that our very own Dr. I. Paul Singh has been recognized by The Ophthalmologist as one of the top ophthalmologists in the world, as nominated by the eye care community. Ranking at an impressive 19 out of 100, this achievement truly reflects Dr. Singh’s passion for people and innovation, both of […]
Read MoreRevolutionary New Glaucoma Treatment iDose
PRESS INFORMATION FOR IMMEDIATE RELEASE: March 1, 2024 The Eye Centers of Racine & Kenosha Announces iDose Revolutionary New Glaucoma Treatment Racine & Kenosha, WI, March 1, 2024 — The Eye Centers of Racine & Kenosha, industry leaders in innovation, (such as Vitreolysis, One- Step Vitrectomy floater treatments, and SMILE which is a next generation […]
Read MoreDry Eye and Glaucoma: A Common Denominator
Read the rest of the article on Modern Optometry Author: Dr. Jeff Banas
Read MoreMiniject Implant
Miniject Glaucoma Draining Device Being involved with research allows the doctors at The Eye Centers of Racine and Kenosha to offer advanced technologies to our patients well before these are available to the general public. Wednesday, March 2nd, Dr. Paul Singh was the first doctor in the Wisconsin to implant the Miniject Glaucoma drainage device, […]
Read MoreMarch Announcements!
Happy March, everyone! Wow, spring really does feel like it is right around the corner! March is a BIG month for us: March 4th is Employee Appreciation Day and in honor of that we will be handing out “goody bags” to staff starting on Thursday. This weekend, our very own Board-certified and fellowship-trained […]
Read MoreDelivering A Stellar Experience With MIGS
With glaucoma entering a paradigm shift in which quality of life is now a primary goal, The Eye Centers of Racine & Kenosha in Wisconsin has been utilizing minimally invasive glaucoma surgery (MIGS) procedures as a means to get patients to reduce their dependency on drops and ultimately improve their overall satisfaction. Read More Here
Read More